New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 7, 2017 – The FDA approved AbbVie’s Norvir (ritonavir) oral powder in combination with other antiretroviral agents for the treatment of pediatric patients with human immunodeficiency virus type 1 (HIV-1) infection.
Download PDF
Return to publications
